HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan-Hua Ding Selected Research

fotagliptin

1/2021Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase-4 Inhibitor: A Randomized, Double-Blinded, Placebo-Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan-Hua Ding Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2018
1Hepatitis B
10/2021
1Chronic Hepatitis B
10/2021
1Common Cold
02/2021
1Human Influenza (Influenza)
02/2021
1Fever (Fevers)
02/2021
1Urinary Tract Infections (Urinary Tract Infection)
03/2018
1Intraabdominal Infections
03/2018
1Hepatocellular Carcinoma (Hepatoma)
08/2017
1Chronic Hepatitis C
01/2017
1Infections
01/2017

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2018
1Hepatitis B e AntigensIBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1pgRNAIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1AntigensIBA
10/2021
1Circular DNAIBA
10/2021
1phillyrinIBA
02/2021
1Benzoates (Benzoate)IBA
01/2021
1fotagliptinIBA
01/2021
1ceftazidime drug combination avibactamIBA
03/2018
1DorzagliatinIBA
01/2018
1GlucokinaseIBA
01/2018
1SodiumIBA
08/2017
1Antiviral Agents (Antivirals)IBA
01/2017
1InterferonsIBA
01/2017